| Overview |
| bsm-62421r |
| CC2D1A Recombinant Antibody |
| WB, Flow-Cyt, ICC/IF |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human CC2D1A |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 54862 |
| Q6P1N0 |
| Coiled coil and C2 domain containing 1A; FREUD 1; Freud 1/Aki1; MRT3. |
| Mediates the levels of long-chain fatty acids (LCFA) in the cell by facilitating their transport across cell membranes.Appears to be the principal fatty acid transporter in small intestinal enterocytes.Also functions as an acyl-CoA ligase catalyzing the ATP-dependent formation of fatty acyl-CoA using LCFA and very-long-chain fatty acids (VLCFA) as substrates, which prevents fatty acid efflux from cells and might drive more fatty acid uptake. |
| Application Dilution |
| WB |
1:300-5000 |
| Flow-Cyt |
FCM1:20-100 |
| ICC/IF |
IFICC1:50-200 |